Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Celyad Oncology (1C0.MU)

Compare
0.4930
0.0000
(0.00%)
As of 8:09:55 AM GMT+2. Market Open.
Loading Chart for 1C0.MU
  • Previous Close 0.4930
  • Open 0.4930
  • Bid 0.4540 x --
  • Ask 0.5340 x --
  • Day's Range 0.4930 - 0.4930
  • 52 Week Range 0.2695 - 0.9600
  • Volume 0
  • Avg. Volume 1
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 1C0.MU

View More

Performance Overview: 1C0.MU

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

1C0.MU
30.86%
BEL 20 (^BFX)
4.66%

1-Year Return

1C0.MU
32.17%
BEL 20 (^BFX)
5.01%

3-Year Return

1C0.MU
76.47%
BEL 20 (^BFX)
3.80%

5-Year Return

1C0.MU
93.56%
BEL 20 (^BFX)
30.29%

Compare To: 1C0.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1C0.MU

View More

Valuation Measures

Annual
As of 4/10/2025
  • Market Cap

    19.47M

  • Enterprise Value

    15.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    253.16

  • Price/Book (mrq)

    20.04

  • Enterprise Value/Revenue

    341.62

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1C0.MU

View More

Company Insights: 1C0.MU

Research Reports: 1C0.MU

View More